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Abstract 
Using a monoclonal antibody-based ELISA, 600 pAN7-l plasmid-tagged mutants of 
Penicillium paxilli were screened for paxilline accumulation and one paxilline negative 
mutant, YI-20, was identified (Itoh, unpublished data) . A molecular analysis of this 
mutant showed that pAN7- l was inserted at a single site but was present as 4-6 copies 
arranged in a head-to tail tandem repeat. Rescue of flanking sequences and analysis of 
the corresponding genomic region revealed that YI-20 has an extensive deletion at the site 
of pAN7- l integration. Probing of a CHEF gel with the same sequences showed that 
associated with the deletion is a rearrangement of chromosome Va. Targeted gene 
disruption of wild-type sequences adjacent to the site where pAN7-l inserted, resulted in 
the generation of two additional paxilline-negative mutants ; both were single crossovers 
with deletions extending outside the region mapped. Neither of these new mutants had a 
rearrangement of chromosome Va, suggesting that deletion of genes on this chromosome 
is responsible for the paxilline-negative phenotype. 
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Chapter One 
Introduction 
1.1 Penidllium paxilli 
Members of the genus Penicillium are widespread throughout nature and most well known 
for their useful metabolite, the antibiotic penicillin. More recently, additional secondary 
metabolites have been isolated from Penicillium. Such metabolites have no known role in 
the organism's living processes (e.g. structure, replication, differentiation, communication 
and/or homeostasis) but are synthesized from either intermediates or end products of 
primary metabolism (Peberdy, 1987). A large group of these secondary metabolites, 
found not only in the Penicillium spp. but also in other filamentous fungi such as 
Aspergillus spp. (Gallagher and Wilson, 1978; Seya et al., 1986; Nozawa et al., 1987), 
Claviceps spp. (Cole et al., 1977; Dorner et al., 1984) and Neotyphodium spp. (Gallagher 
et al., 1984) are known as tremorgenic mycotoxins. These toxins are fungal metabolites 
that affect the central nervous system function in vertebrates. An example of such a 
tremorgen is the indole-diterpenoid, paxilline, (Fig. 1.1) produced by Penicillium paxilli. 
Penicillium paxilli, an asexual saprophytic fungi, was first isolated from insect-damaged 
pecans in the state of Georgia, USA (Cole et al ., 1974 ). This fungus grows rapidly, 
sporulates readily and produces large amounts of paxilline in submerged culture. 
Production of paxilline by P. paxilli was found to cause tremors when fed to both 
cockerels and mice (Cole et al., 1974). Also reported, is the isolation of P. paxilli from the 
faeces of cattle in Victoria, Australia and soil from pastures in South Australia (Cockrum et 
al., 1979). However, these two isolates did not produce the characteristic paxilline but 
substantial quantities of the tremorgenic toxin verruculogen, a prenylated diketopiperazine 
(Cockrum et al., 1979). Although structurally different from paxilline, verruculogen 
contains both indole and isoprene moieties. 
UV and IR spectra show that paxilline contains indole (Cole et al., 1974) and its structure 
was determined by X-ray diffraction analysis. Data from labelling studies (Acklin et al., 
1977; de Jesus et al., 1983; Laws and Mantle, 1989) show that both radiolabelled 
tryptophan and mevalonic acid are primary precursors of paxilline, where the incorporation 
of four mevalonate molecules indicates an involvement in isoprenoid biosynthesis (Fig. 
1.2). 
Secondary metabolites that contain tryptophan derivatives usually retain the aliphatic side 
chain. However, this tremorgenic mycotoxin has lost both the a.- and ~-carbons 
(Peberdy, 1987). Other such mycotoxins, which contain a single nitrogen atom as part of 
an indole nucleus and also have similarities with much of the indole-diterpene structure, 
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Ffg. 1.2 The Proposed Indole-Diterpenoid Pathway 
A schematic diagram showing the boundaries of primary and secondary metabolism within the indole-diterpenoid biosynthetic pathway. 
have been grouped into four structural classes (Fig. 1.1 and 1.2): (i) the janthitrems 
(Gallagher et al., 1980), (ii) the lolitrems (Gallagher et al., 1984 ), (iii) the paspalitrems 
(Cole et al., 1977; Dorner et al., 1984) and (iv) the penitrerns (de Jesus et al., 1983). 
Although arising from a diverse range of fungal species, all of these compounds appear to 
share a common structural backbone of paxilline (Fig 1.1) and are known to be 
tremorgenic. Paxilline has been readily found in a range of fungi known to produce these 
indole-diterpenoids (Seya et al., 1986; Weedon and Mantle, 1987), and labelling studies 
using [1 4C]paxilline have shown that it is incorporated into the penitrems (Mantle and 
Penn, 1989), supporting the theory that paxilline is a key intermediate for these indole-
diterpenoids. 
Munday-Finch et al. ( 1996) have proposed a metabolic grid for paxilline production where 
the initial reaction must be prenylation of indole with geranylgeranyl diphosphate, a 20 
membered carbon isoprenoid. Beyond this point, by looking at the individual structural 
changes between each of the intermediates it maybe possible to predict the type of enzymes 
that would be associated with this pathway. 
1.2 Paxilline Biosynthesis 
1.2.l Primary Metabolism - The Indole Moiety 
It has long been thought that the indole group of the indole-diterpenoids is incorporated 
from tryptophan that has lost the aliphatic side chain possibly by tryptophanase activity. 
This theory has arisen from the fact that tryptophan synthase catalyses the reaction of 
indole-3-glycerol phosphate to tryptophan via an indole intermediate that is not released 
(Stryer, 1995). Tryptophan synthase is a bifunctional enzyme with two different domains, 
an a-subunit (TSA) and a ~-subunit (TSB). TSA catalyses the first reaction of indole-3-
glycerol phosphate to indole. However, the indole is never released but passes down a 
'tunnel' to the P-subunit. It is in TSB that indole is converted to tryptophan and released. 
The role of tryptophan synthase means that any available indole is sequestered and, 
therefore, tryptophan could be the only precursor for indole-diterpenoid biosynthesis. 
However, Frey et al. (1997) have recently shown that in addition to the tryptophan 
synthase a- and P-subunits there is evidence for an independently acting TSA subunit 
involved in the biosynthesis of two cyclic hydroxamic acids that form part of the defence 
against insects and microbial pathogens of maize. As labelling studies to date (Acklin et 
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al., 1977; de Jesus et al., 1983; Laws and Mantle, 1989) have not addressed the issue of 
direct incorporation of indole, it is possible that a TSA-like enzyme is responsible for the 
indole supply instead of tryptophanase. If such a TSA enzyme was involved with paxilline 
biosynthesis, it would have to be dedicated to this pathway, therefore, there would be a 
need for two TSA-like subunits within the genome. One would be associated with primary 
metabolism and the TSB subunit producing tryptophan while the other, remaining 
independent and used for secondary metabolism. 
1.2 .2 Primary Metabolism - The Diterpenoid Moiety 
Isoprenoids are a structurally diverse group of compounds (Chappell , 1995), which can be 
divided into primary (e.g . sterols, gibberellic acid, carotenoids and those involved in 
protein prenylation) and secondary metabolites (e.g. monoterpenes, sesquiterpenes and 
diterpenes). The isoprenoid pathway involves the sequential condensation of three acetyl-
CoA units to generate 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA), which is 
converted to the six carbon mevalonate in an irreversible reaction catalysed by HMG-CoA 
reductase (Fig. 1.2) Isopentenyl diphosphate (IPP) and its isomer, dimethylallyl 
diphosphate (DMAPP), are generated by phosphorylation and decarboxylation of 
mevalonate . It is IPP and DMAPP that are the five-carbon building blocks for all other 
isoprenoids. Condensation of IPP and DMAPP in a head-to-tail manner generates geranyl 
diphosphate (GPP); addition of another IPP molecule generates farnesyl diphosphate 
(FPP) and addition of a third IPP molecule generates geranylgeranyl diphosphate (GGPP). 
The polymerisation reactions are catalysed by a series of enzymes known as 
prenyltransferases that are associated with primary metabolism (Fig. 1.2). The group of 
enzymes responsible for cyclisation of GPP, FPP and GGPP, the terpene, sesqui- and 
diterpene cyclases, utilise a similar reaction mechanism to the prenyltransferases. 
Recent studies in Neurospora crassa (Barbato et al., 1996) using RIP (Repeat-Induced 
Point Mutation) suggests that a complete knockout of the geranylgeranyl diphosphate 
synthase gene (al-3) would be lethal. It appeared that RIP would not introduce more than 
six point mutations and these mutations were leaky, leaving a partially functional enzyme. 
Disruption of the geranylgeranyl di phosphate synthase gene (EST 1) in Saccharomyces 
cerevisiae (Yiang et al., 1995) showed that BSTJ was not essential for the vegetative 
growth of the yeast cells but, in its absence, growth is impaired at temperatures of 25°C 
and below. These results suggest that a knockout of geranylgeranyl diphosphate synthase 
would result not only in the loss of indole-diterpenoid biosynthesis but also would have a 
large effect on the fungal growth. 
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1.2.3 Secondary Metabolism - Paxilline Production 
The putative pathway for paxilline biosynthesis (Munday-Finch et al., 1996) has been 
deduced by the presence of likely chemical intermediates and logical progression of the 
chemical structures. It is thought that paxilline biosynthesis must begin with the 
prenylation of indole or tryptophan with GGPP, as well as cyclisation of the 20 carbon 
isoprenoid unit by a diterpene cyclase or synthase resulting in paspaline. Paspaline is 
oxidised to paspaline B which undergoes oxidative decarboxylation followed by allylic 
oxidation to give paxilline. Therefore, based on the need for progressive chemical 
oxygenation of putative intermediates, one would expect the involvement of oxygenases 
such as cytochrome P450 monooxygenases. Other expected enzymes include hydrolases 
and decarboxylases. However, until the pathway has been elucidated biochemically, 
proposed steps would be only speculative. 
Due to the similar structures of paxilline and the other indole-diterpenoid compounds (Fig. 
1.1) determination of the paxilline biosynthetic pathway should allow easy isolation of the 
genes responsible for the other pathways, such as the lolitrems, paspalitrems, penitrems 
and janthitrems. 
1.3 Gene Clusters 
Fungal gene clusters have been broadly defined as the close linkage of two or more genes 
that participate in a common metabolic or developmental pathway. Clusters commonly 
found are those of dispensable pathways such as nutrient utilization and the production of 
secondary metabolites (Keller and Hohn, 1997). These pathways are not required for the 
normal growth of the organism but are thought to be present for selectional advantages, in 
particular, as a response to nutrient deprivation or competing organisms. Gene clusters 
have only recently been found in filamentous fungi. Since the 1980s there has been 
genetic evidence, using pathway mutants, that established the likely clustering of some 
genes responsible for aflatoxin biosynthesis (Bennett and Papa, 1988). However, the first 
molecular evidence of a fungal gene cluster did not arise until 1989, when Hull et al. 
( 1989) found the L-proline catabolic pathway of A. nidulans. 
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As many prokaryotic metabolic pathways are clustered and due to similarities seen between 
some of the fungal and prokaryotic pathways, it is proposed that some fungal-pathway 
gene clustering may have evolved from horizontal gene transfer from prokaryotes. A good 
example of this is the isopenicillin N synthase gene from Streptomyces lipmanii and 
Aspergillus nidulans, where similarities also include the lack of intrans and high GC 
content (Weigel et al ., 1988). 
1. 3 .1 Dispensable Cntabolic Pathways 
To date, four dispensable catabolic pathways (quinate, ethanol, praline and nitrate 
utilisation) are found to be clustered in the filamentous fungus A. nidulans (reviewed by 
Keller and Hohn, 1997). These clusters are in the size range of 12 - 18 kb and appear to 
contain genes encoding biosynthetic enzymes, transcription factors and transporters. 
Although some of these pathways are clustered in other fungi , this is not always the case. 
For example, praline utilisation in S. cerevisiae is not clustered, while protein function is, 
however, still conserved. 
1.3.2 Secondary Metabolite - Penicillin 
Since the Second World War there has been a large focus on the production of the P-lactam 
derivatives, the penicillins and cephalosporins. This would make the penicillin 
biosynthetic pathway the most well studied of all the secondary metabolites produced by 
filamentous fungi. Although chemists have tried to establish commercial chemical 
synthesis of the penicillins, the highly sensitive P-lactam ring does not withstand this, 
leaving fermentation as the most efficient way of isolating large quantities of penicillin. It 
was in the 1960s that isolation of linear o-(a-aminoadipyl)-cysteinyl valine (ACY) from P. 
chrysogenum gave the first evidence that penicillin was a tripeptide made of cysteine, 
valine and a-aminoadipic acid. In the 1980s the penicillin genes were isolated, with the 
first evidence of a gene cluster adduced in 1989 by Barredo et al., ( 1989). 
The penicillin gene cluster of Penicillium chrysogenum is approximately 20 kb, containing 
three genes that encode the biosynthetic enzymes, ACY synthetase, isopenicillin N 
synthetase and acyltransferase. These genes are also known to be clustered in A nidulans 
and in the cephalosporin-producing Acremonium chrysogenum. 
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1.3.3 Secondary Metabolite -Trichothecenes 
Fusarium, a fungus known to cause dry rot in potato tubers, produces a family of toxic 
sesqui terpenoids, the trichothecenes. These mycotoxins accumulate in agricultural 
products, are potent inhibitors of eukaryotic protein synthesis and are thought to be 
involved with plant diseases . Trichothecenes are formed from the primary metabolite, 
farnesyl diphosphate (FPP) by cyclisation catalysed by trichodiene synthase followed by 
subsequent modification of trichodiene through a series of oxygenation steps. Isolation of 
trichodiene synthase showed that it is the first committed step in trichothecene biosynthesis 
(Beremand, 1987; Hohn and Beremand, 1989). Evidence of a gene cluster was shown by 
Hohn et al. ( 1993) with the isolation of two overlapping cosmid clones that complemented 
mutants which blocked the trichothecene pathway . To date, the gene cluster from 
Fusarium sporotrichioides is thought to be -25 kb with nine genes. Of the six biosynthetic 
enzymes, two share sequence identity with cytochrome P450 monooxygenases, three 
share sequence identity with acetyltransferases and the other, based on enzyme activity, is 
trichodiene synthase. The three remaining genes include a transcription factor that is 
required for pathway expression (Proctor et al ., 1995), an apparent transport protein, and 
one gene with no known function (Keller and Hohn, 1997). 
1.3.4 Secondary Metabolite - Ajlatoxin/ Sterigmatocystin 
The polyketide mycotoxins, aflatoxin and sterigmatocystin, are potent carcinogens 
produced by the fungi Aspergillus flavus , A . parasiticus (aflatoxin) and A. nidulans 
(sterigmatocystin). These fungi infect corn, cotton and peanuts and are a major threat to 
the health of humans. Evidence for a gene cluster in A. parasiticus was based on the 
isolation of the closely linked aflatoxin genes, ver-1 and nor-1 (Skory et al., 1992), while 
physical mapping of the A. flavus apa-2, an aflatoxin regulatory gene, placed it 
approximately 8 kb away from ver-1 (Chang et al., 1993). Keller et al. (1994) found 
evidence that the sterigmatocystin pathway is clustered, when they isolated the verA gene 
from A. nidulans. Two other open reading frames were found alongside the verA gene, 
one was predicted by sequence identity to encode a P450 monooxygenase (Keller et al., 
1994). As with the trichothecene pathway, such genes are expected to be involved with 
sterigmatocystin and aflatoxin synthesis. The complete sterigmatocystin biosynthetic 
cluster of A. nidulans has been published (Brown et al., 1996) with similarities between 
the two gene clusters of aflatoxin and sterigmatocystin reviewed by Keller and Hohn 
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( 1997). Although the order of the genes is not identical, the two clusters possess similar 
gene function and regulatory control. The 60 kb sterigmatocystin cluster contains 25 
genes; 16 encoding biosynthetic enzymes, one regulatory gene and eight with unknown 
functions. Of the 16 biosynthetic enzymes, five show similarity to P450 
monooxygenases, four are dehydrogenases and the remaining enzymes include an 
esterase, an O-methyltransferase, a reductase and an oxidase. The boundary of the gene 
cluster was determined by Northern analysis as fragments that hybridised under both 
sterigmatocys tin-inducing and non-sterigmatocystin-inducing conditions (Brown et al., 
1996). At present it is the aim of these groups to knockout each of the genes individually 
to determine their function. 
1. 3 .5 Secondary Metabolite - Melanin 
Melanins are high-molecular-weight, coloured pigments produced by numerous fungi. 
They give the fungus protection from desiccation, UV irradiation and extreme temperatures 
as well as cell wall rigidity. They are also thought to be associated with the ability of 
certain fungal plant pathogens to penetrate host plant cells. Melanins are formed by the 
oxidative polymerisation of phenolic compounds with the precursors being either 
polyketide products or tyrosine. A three-gene cluster containing a polyketide synthase, 
scytalone dehydratase and 1,3,8-trihydroxynaphthalene synthase was identified in the non-
pathogenic fungus Altemaria altemata (Kimura and Tsuge, 1993). However, with the 
pathogenic fungi Colletotrichum lagenarium and Magnaporthe grisea, for example, these 
genes are not clustered. 
1.3.6 Secondary Metabolite - Paxilline 
Paxilline, is a known secondary metabolite from P. paxilli, that is not required for normal 
growth and development of this fungus. To date, there is no genetic evidence available, to 
show that the paxilline biosynthetic genes are clustered. However, as many fungal 
secondary metabolites are clustered (Section 1.3. l - 1.3.5) it is also thought the paxilline 
biosynthetic genes maybe. 
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1.4 Approaches to Cloning Secondary Metabolite Genes 
1.4.1 M utagenesis 
UV and chemical mutagenesis have been used for a number of years to isolate a large 
number of mutants. The advantage of such a system is that a large quantity of random 
mutants can be quickly isolated with no knowledge of the genes involved. Although easy 
to perform, there are several drawbacks for using random mutagenesis: (i) there is the 
possibility of more than one mutation per genome; (ii) the mutations are not tagged in any 
way makjng it difficult to isolate the mutated gene; (iii) large numbers of mutants have to 
be screened to identify the phenotype of interest. However, once mutant has been isolated, 
several strategies can be used to identify the gene responsible. Beremand (1987) used UV 
mutagenesis to generate 1000 mutants of Fusarium sporotrichioides. Using a rrucrotitre 
plate to grow the cultures, Beremand (1987) was able to rapidly screen these mutants by a 
monoclonal antibody to trichothecene. The three mutants identified were characterised 
cherrucally for their role in trichothecene biosynthesis . Complementation with a cosrrud 
library of F. sporotrichioides genomic DNA containing a hygromycin selectable marker 
was used to rescue two trichothecene-deficient mutants (Hohn et al. , 1993). The cosmids 
were characterised further to deterrrune the sequences responsible for complementation of 
the different mutations. 
An alternative approach is that of heterologous plasmid tagging by integrative 
transformation of a plasrrud that has no homology with the fungal genome. The plasrrud, 
such as pAN7- l (Punt et al., 1987), contains a fungal selectable marker ( e.g. a gene for 
hygromycin resistance) and is thought to integrate into the genome of the fungal 
protoplasts by illegitimate recombination at the site of chromosome nicks or breaks (Fig. 
3A). More recently, plasmid tagging has been modified by the addition of a restriction 
enzyme (Restriction Enzyme Mediated Integration - REMI) during the transformation 
process (Schiestl and Petes, 1991 ). A plasmid carrying a fungal selectable marker is 
linearised with a suitable restriction enzyme and used to transform fungal protoplasts in the 
presence of the restriction enzyme. Integration of the plasmid occurs at the restriction 
enzyme target site presumably due to cleavage with the enzyme (Fig. 1.3B). This plasmid 
tagging method has proven very successful with a number of fungi and is found to 
increase the transformation frequency and favour the integration of the plasmid as a single 
copy . REMI was shown to increase the Cochliobolus heterostrophus transformation 
frequency from 6 up to as many as 107 transformants per 30 µg of linear DNA per 106 
1 0 
A 
B 
H H 
B H B 
B H B 
B H 
j 
OR 
H 
H H 
pRN7-1 0 
B 
j WodIII °"" ge,omk Hi,,dlll , t<c 
B B 
j Hi,,dlll rni ,ocioc "'"''""' ioio g<oomi, HiodlIT , i<c 
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A Illegitimate recombination 
B Restriction Enzyme Mediated Integration (REMI) 
The integrating plasmid (pAN7-1) is red . The restriction enzyme is blue. Genomic DNA 
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11 
protoplasts when a restriction enzyme was included (Lu et al. , 1994). Of the 1310 
transformants isolated, two failed to produce detectable T-toxin and virulence to maize was 
lost. Characterisation of these mutants showed the Tox- mutation of the two transformants 
mapped to the expected Toxl locus (Lu et al., 1994). DNA recovered from the insertion 
s ite of one mutant encodes a 7. 6 kb open reading frame that identi fied a multi functional 
po lyketide synthase (Yang et al., 1996). Analys is of 1000 REMI insertion mutants of the 
maize pathogenic fu ngus U stilago maydis demonstrated that 1-2 % of these mutants were 
unab le to induce symptoms when tested in planta. Characterisation of two of these 
mutants showed that the phenotype is linked to the insertion event (Ba lker et al., 1995). 
With all mutagenesis techniques there is a requirement to screen large numbers of mutants 
to fi nd the phenotype of interest. Therefore, an observable phenotype is very useful , fo r 
example, spore pigmentat ion (Itoh and Scott, 1994) or an ability to produce carotenoids 
such as those that give N. crassa its orange colour (Barbato et al., 1996). However, for 
most mutants an observable phenotype is not available. More time-consuming screens 
involve in planta assays for pathogenicity (Ba lker et al., 1995) or extractio n of the 
compound of interes t for analys is by TLC (Hodges et al., 1994 ). Monoclonal-based 
ELISA are useful fo r quick screening of cu lture fil trates for compounds of interest 
(Beremand, 1987) . Such techniques have a quick assay system. However, the anti body 
needs to be reasonably specific for the compound being observed. 
The advantage of plasmid tagging over the other mutagenes is techniques is the ability to 
rescue the tagged gene via plasmid rescue . Of course, there is sti ll the labour intensive 
screen fo r transformants wi th the appropriate phenotype, as is also required fo r UV 
mutagenesis . 
1.4.2 Enzyme Isolation 
When an enzyme has a known biochemical activity that can be assayed it is possible to 
isolate the protein. A number of secondary metabolite genes have been found as a result of 
protein purification. Tricodiene synthase, the enzyme that catalyses the isomerisation and 
cyclisation of FPP to tricodiene, was isolated from Fusarium sporotrichioides. Antibodies 
to this enzyme were made and used to screen a A.gt 11 expression library to F . 
sporotrichioides. The resulting cloned DNA was sequenced and compared to the known 
protein sequence from CNBr cleaved fragments , confirming that the gene was tricodiene 
synthase. An internal fragment from the cDNA was used to isolate a cosmid containing the 
complete gene sequence. Expression of this gene and biochemical analysis confirmed the 
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tricodiene synthase activity (Hohn and Beremand, 1989). Tsai et al. ( 1995) used a slightly 
different approach. The isolated enzyme, dimethylallyl tryptophan synthase (DMAT), was 
first purified from mycelia of Claviceps purpurea (Gebler and Poulter, 1992). This 
enzyme is responsible for the alkylation of L-tryptophan by dimethylallyl diphosphate and 
is the first pathway-specific step of ergot alkaloid biosynthesis. Partial sequence of CNBr 
fragments was used to design degenerate primers that hybridised to C. purpurea genomic 
ON A. PCR was used with these primers and the nucleotide sequence compared to the 
available OMA T peptide sequence. The complete OMA T gene was cloned and sequenced, 
and its function confirmed by expression in a yeast background. 
For the above method to be useful, protein sequence data are required. These are not 
always available and enzyme purification can be a lengthy process even with a biochemical 
assay. With the sequence databases increasing rapidly in size everyday, it is often possible 
to obtain and compare known protein sequences. If there is sufficient identity between the 
proteins, degenerate primers can be designed and used for PCR. The drawback of this 
system is finding regions of the sequence that contain enough identity with amino acids 
that have low codon usage . Unfortunately many proteins have similar activity but 
sequence conservation can be limited to a catalytic domain or an active site. 
1.4.3 Heterologous probing 
Aspergillus species are known to produce the similar compounds aflatoxin and 
sterigmatocystin. As a number of genes have been isolated from the aflatoxin-producing 
fungi, A. parasiticus and A. flavus, it is possible to use these cloned fragments for the 
isolation of homologues in A. nidulans. The ver-1 gene from A. parasiticus is responsible 
for the enzymatic conversion of versicolorin A to sterigmatocystin (Skory et al., 1992). 
Heterologous hybridisation was used to isolate ver-l homologue from A. nidulans (Keller 
et al., 1994). The hybridising fragment was subcloned from a cosmid and sequenced. 
This technique has also been used for the isolation of dothistromin genes. Dothistromin is 
a polyketide toxin produced in pine by the fungus Dothistroma pini. As the chemical 
structure of dothistrorrtin is similar to aflatoxin, similar enzymes maybe responsible for its 
production. Heterologous probing with the ver-1 gene from A. parasiticus was used to 
isolate the D. pini homologue from a genomic library (Gillman and Bradshaw, personal 
comm.). Sequence data show that the D. pini ver gene has 75% identity to the A . 
parasiticus gene (Monahan and Bradshaw, personal comm.). 
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1.4.4 Differential screening 
In recent years, there has been a number of RNA-based techniques established for looking 
at differentially expressed genes, Different culture conditions (e,g, temperature, time and 
nutrient sources) can induce or repress gene expression, these conditions are then used for 
RNA isobtion, The earliest of these techniques was subtractive hybridisation, Feng er al, 
( 1992) used growth phase, carbon source and temperature to distinguish differential 
expression of genes related to af1atoxin biosynthcsis, The three labeled cDNA probes were 
hybridised successively to the same membranes hosting the DNA library, When 
compared, 0.6% of the 20 000 colonies were found to differentially hybridise to the three 
probes, These clones were screened against Northern blots to further prove their 
expression pattern, 
Another differential screening method is that of differential display (DD) (Liang and 
Pardee, 1992), This is a PCR-bascd technique that compares differences in mRNA 
content between two different states, Total RNA isolated from cultures grown under 
different physiological conditions is amplified by reverse transcriptase with poly-T tailed 
anchored primers, These primers anneal to the poly-A tail of the mRNA and are anchored 
at the 3' end by A, C or G nucleotides, The second round of PCR uses the anchored poly-
T primer with a primer of arbitrary sequence, This reduces the pool of represented mRt'\!A 
so the fragments can be separated on a denaturing geL The bands from the different 
growth conditions are compared to find fragments that are differentially expressed, These 
bands are isolated, reamplified and used to screen Northern blots to confirm their 
expression pattern, 
L4.5 Proteonome Analysis 
There have been great advancements with two-dimensional (20) gel electrophoresis of 
proteins, and with NMR and mass spectrophotometry for obtaining a protein sequence 
from a small sample, This has resulted in a revival in proteonome analysis, where the 
proteins of two physiological states are compared by 2D gel electrophoresis, Any proteins 
that are differentially expressed can be sequenced by mass spectrophotometry directly from 
the geL It is also possible to determine protein function by comparison of 2D gel libraries 
of known proteins, 
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1.5 Genetic Criteria to Confirm Functionality of the 
Isolated Gene. 
Once a potential gene is isolated, there needs to be a way of confirming its actual 
physio logical role. In sexual fungi, crosses can be used to determine whether the 
phenotype and marker co-segregate. However, this approach cannot be used with asexual 
fungi and, therefore, other methods are required. In many cases, complementation can be 
used when a gene has been knocked out. When replacing it with a functional gene, the 
wild-type phenotype should be restored. This is not always possible due to the lack of 
available selectable markers for filamentous fungi. When complementation is not possible, 
homologous recombination can be used to knockout the gene of interest in a wild-type 
strain, resulting in a recessive phenotype. This approach can be lengthy as the double 
crossover integration event required for a true knockout occurs at a low frequency and is 
locus dependent (Bird et al., 1997). 
1.6 Cloning of the Paxilline Biosynthetic Genes in 
Penicillium paxilli by Plasmid Integration 
As the genes of many fungal secondary metabolite pathways are arranged in clusters, it 
would be of no surprise to find this the case for the paxilline biosynthetic genes. To isolate 
such genes from P. paxilli the approach initiated was that of heterologous plasmid 
integration using a monoclonal-based competitive ELISA (Garthwaite et al., 1993) to 
screen for the loss of paxilline production. If the genes responsible for paxilline 
biosynthesis are found in a cluster, random plasmid integration into one of these genes, 
would knock out paxilline production. Therefore, isolation of sequences flanking the 
plasmid integration site and the surrounding locus would result in the cloning of the 
clustered genes. 
Itoh et al. (1994) used pAN7-1 (Appendix Al. 1) to isolate 600 tagged transformants of P. 
paxilli. A sub-group of these transformants was checked for stability, frequency and 
randomness of integration. Up to 78% of the transformants contained the plasmid at a 
single site, and 50% of these transformants were present as a tandem repeat. The 
integration of the plasmid into the genome did not appear to be site specific. In contrast, 
work with Aspergillus nidulans using heterologous plasmid integration showed site-
selectivity (Diallinas and Scazzocchio, 1989; Tilbum et al., 1990). Within the 600 
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pAN7-1 tagged transformants, 0.83% had a characteristic brown spore phenotype. 
Isolation and characterisation of mutants in this spore pigmentation locus showed that the 
integration of pAN7-l had caused extensive deletions through a common region of the 
genome (Itoh and Scott, 1994 ). All of the above mutants were also screened by the 
cELISA (Fig. 1.4) for their ability to produce paxilline in culture. The antibody used in 
this assay recognises both paxilline and an array of compounds structurally related to 
paxilline. One mutant, YI-20, had a paxilline negative phenotype as determined by 
cELISA and HPLC. Characterisation of this mutant by Southern analysis (Fig 1.5) 
showed that the integrating plasmid, pAN7-1, was present at a single site but in a head-to-
tail tandem repeat. Hybridisation of genomic digests of YI-20 DNA with pAN7-1, shows 
bands present at 6.8 kb in the BamHI (lane 2) and HindIII (lane 3) digests, indicative of a 
tandem repeat (Itoh, unpublished data). 
1.7 Aim 
The aim of this thesis is to characterise the Pax- mutant, YI-20, with respect to its 
integration of pAN7-1 and to establish whether plasmid integration was responsible for the 
phenotype observed. The genomic sequence surrounding the pAN7-1 integration will be 
isolated. These sequences will be used to make a replacement construct with the intent to 
generate additional paxilline-negative mutants via homologous recombination. The 
resulting mutants will be characterised for their ability to produce paxilline and for their 
integration events. 
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Southern analysis of the integration of pAN7-1 in YI-20 
Southern analysis of YI-20 genomic DNA digested with EcoRl (lane 1), BamHI 
(lane 2), HindIII (lane 3), hybridised with pAN7-1. Lane M, 'A. HindIII. 
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